JP Morgan Chase’s Mural Oncology MURA Stock Holding History

JP Morgan Chase’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-232	Closed	-$480	–	7647
2025 Q3	$480	Sell	232 -204	-47%	-$438	﹤0.01%	7054
2025 Q2	$1.08K	Sell	436 -47	-10%	-$111	﹤0.01%	6614
2025 Q1	$609	Buy	483 +240	+99%	+$875	﹤0.01%	6680
2024 Q4	$782	Sell	243 -3	-1%	-$11	﹤0.01%	6759
2024 Q3	$770	Sell	246 -1,725	-88%	-$5.62K	﹤0.01%	6750
2024 Q2	$6.19K	Sell	1,971 -17,692	-90%	-$65.2K	﹤0.01%	6341
2024 Q1	$96.2K	Sell	19,663 -15,485	-44%	-$75.2K	﹤0.01%	5692
2023 Q4	$208K	Buy	+35,148	New	+$141K	﹤0.01%	5370

JP Morgan Chase's MURA Position: Q4 2025 in Review

JP Morgan Chase sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 232 shares — an estimated $480 sold.

JP Morgan Chase first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $208K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

JP Morgan Chase reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
JP Morgan Chase sold 232 Mural Oncology shares in Q4 2025, an estimated $480.
JP Morgan Chase first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
JP Morgan Chase's Mural Oncology position peaked at $208K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.